https://orcid.org/0000-0002-0993-0525
References
- MS A-S, Jamous RM, Alothman NHA, et al. Genotyping and antifungal susceptibility of Candida albicans strains from patients with vulvovaginal and cutaneous candidiasis in Palestine. Afr J Microbiol Res. 2015;9:952–959.
- Ashrafi Iradj T, Zahraei Taghi S, Sharifzadeh A, Shokri H, Khosravi AR. Repetitive sequences based on genotyping of Candida albicans isolates obtained from Iranian patients with human immunodeficiency virus. Iran J Basic Med Sci. 2014;17:831–835.25691923
- Gurbuz M, Kaleli I. Molecular analysis of Candida albicans isolates from clinical specimens. Mycopathologia. 2010;169:261–267.20012366
- Haddadi P, Zareifar S, Badiee P, et al. Yeast colonization and drug susceptibility pattern in the pediatric patients with neutropenia. Jundishapur J Microbiol. 2014;7:11858.
- Hattori H, Iwata T, Nakagawa Y, et al. Genotype analysis of Candida albicans isolates obtained from different body location of patients with superficial candidiasis using PCRs targeting 25S rDNA and ALT repeat sequences of the RPS. J Dermatol Sci. 2017;42:31–46.
- Iwata T, Hattori H, Chibana H, et al. Genotyping of Candida albicans on the basis of polymorphisms of ALT repeats in the repetitive sequence (RPS). J Dermatol Sci. 2006;41:43–54.16364601
- Karahan ZC, Guriz H, Agrbasal H, et al. Genotype distribution of Candida albicans isolates by 25S intron analysis with regard to invasiveness. Mycosis. 2014;47:465–469.
- Li JY, Sun HY, Zhang QQ. Antifungal susceptibility test of genotypes of Candida albicans from patients with atrophic or erosive oral lichen planus. Shanghai Kou Qiang Yi Xue. 2011;20:300–303.21779742
- Luo X, Dong X, Distribution PZ. Drug susceptibility of Candida spp. associated with female genital tract infection, Chongqing, China. Jundishapur J Microbiol. 2015;8(9):e19386.
- McCullough MJ, Clemons KV, Stevens DA. Molecular and phenotypic characterization of genotypic Candida albicans subgroups and comparison with Candida dubliniensis and Candida stellatoidea. J Clin Microbiol. 1999;37:417–421.9889231
- Mijiti J, Pu XM, Erfan A, Yaguchi T, Chibana H, Tanaka R. Genotyping of fluconazole-resistant Candida albicans isolated from Uighurian people in Xinjing (China) using ALTS/RFLP and micro-TGGE method. Nihon Ishinkin Gakkai Zasshi. 2010;51:165–168.20716855
- Millar BC, Moore JE, Xu J, Walker MJ, Hedderwick S, McMullan R. Genotypic subgrouping of clinical isolates of Candida albicans and Candida dubliniensis by 25S intron analysis. Lett Appl Microbiol. 2002;35:102–106.12100582
- Sawadogo PM, Zida A, Sangaré I, et al. Genetic mutations conferring resistance to candida albicans to antifungal drugs: a global perspective and regional implications. J Infectiology. 2019;2(4):6–12.
- Tamura M, Watanabe K, Mikami Y, Yazawa K, Nishimura K. Molecular characterization of new clinical isolates of Candida albicans and C. dubliniensis in Japan: analysis reveals a new genotype of C. albicans with group I intron. J Clin Microbiol. 2016;39:4309–4315.
- Tapia CV, Hermosilla G, Fortes P, et al. Genotyping and persistence of candida albicans from pregnant women with vulvovaginal candidiasis. Mycopathologia. 2017;182:339–347.27882525
- Vrioni G, Matsiota-Bernard P. Molecular typing of Candida isolates from patients hospitalized in an intensive care unit. J Infect. 2011;42:50–56.
- Zarei Mahmoudabadi A, Zarrin M, Kiasat N. Biofilm formation and susceptibility to amphotericin B and fluconazole in Candida albicans. Jundishapur J Microbiol. 2014;7:28–36.
- Zida A, Soulama I, Bamba S, et al. 25S rDNA genotype and antifungal susceptibility of clinical Candida albicans in Ouagadougou (Burkina Faso). Med Mycol. 2017;56:61–65.